As one of the most marketable industries, pharmaceutical grade magnesium oxide market competition is very intense. Depending on the core technology, Hebei Meishen Technology Co., Ltd broke the monopoly from international giants. Chinese pharma grade magnesium oxide shocks international bulk pharmaceutical market. Meishen’s pharma grade MgO became Chinese important MgO bulk pharmaceutical chemicals, and Meishen became the largest pharmaceutical grade magnesium oxide production base in China.
For a long time, Meishen Technology has committed to magnesium oxide technical transformation and self-dependent innovation. Its technical center adopts incentive systems of hire at high salary and technology appraised as capital stock, and hire men of virtue and talents through talent exchange and other ways. At present, Meishen has already set up staff team and technical team which takes doctors, masters, bachelors and junior college students as the main body. What’s more, it built magnesia material R&D center, and established good cooperative relations with Chinese Academy of Sciences and Tsinghua University. It has already successfully developed pharmaceutical grade and food grade magnesium oxide, magnesium carbonate, magnesium sulfate and series of products.
Until now, Meishen Technology has already set up numbers of pharma grade magnesium oxide production line. The process scale can achieve more than 3000 tons every year, and occupies the top in China. The products sold over 30 domestic provinces and cities, regions. At the same time, Meishen actively explores the international market, exports to Italy, Korea, Japan, and so on. The market share occupies 40 percent of Asia market.